Latest News about GSK
Recent news which mentions GSK
GSK Touts Encouraging Data From Mid-Stage Tuberculosis Program In Drug-Susceptible Patients
November 14, 2022
Tickers
GSK
From Benzinga
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
November 11, 2022
Tickers
GSK
From MarketWatch
GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations
November 11, 2022
Tickers
GSK
From Benzinga
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
From MarketWatch
GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care
November 07, 2022
Tickers
GSK
From Benzinga
Why Vir Biotechnology Jumped Nearly 19% Today
November 04, 2022
From Motley Fool
Moderna's Earnings Collapsed. Time to Sell?
November 04, 2022
From Motley Fool
Citing Efficacy, GSK Stops Two Pivotal UTI Antibiotic Trials Early
November 03, 2022
Tickers
GSK
From Benzinga
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02
November 02, 2022
From Benzinga
Tickers
GSK
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
From Benzinga
Is Merck Moving Toward Another Blockbuster Drug Launch?
October 26, 2022
From Motley Fool
GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day
October 25, 2022
From Benzinga
From Benzinga
Children's Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids
October 21, 2022
From Benzinga
From Benzinga
3 Things the Smartest Investors Know About This Beaten-Down Stock
October 20, 2022
From Motley Fool
7 Quality Stocks Selling at a Discount as Q4 Kicks Off
October 19, 2022
From InvestorPlace
This Addiction Drug Shows Some Potential Against Long COVID Symptoms
October 19, 2022
From Benzinga
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
October 17, 2022
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
